Simbryo Technologies, Inc.
PrivateLast Round
Seed
Nov 1, 2025
Total Funding Raised
$10,000
Company Overview
Simbryo Technologies, Inc. is a biotechnology company that develops precision diagnostic tools using patient-derived endometrial organoids to assess endometrial fertility and improve IVF success rates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simbryo Technologies, Inc. Comparables
Compare Simbryo Technologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cicero Diagnostics, Inc. | 81% | |
| Vitrolife AB | 78% | |
| CERTANIA Holding GmbH | 78% | |
Simbryo Technologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Grant | Sep 17, 2025 |
Simbryo Technologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keyhorse Capital | Seed |
| Cintrifuse Capital | Seed |
Simbryo Technologies, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Simbryo Technologies, Inc.'s valuation, stock price, and market status.